Skip to main content
SpringerLink
Log in

HPV vaccine cost saving for CIN and FIGO 1A in Netherlands

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. International Federation of Gynecology and Obstetrics

  2. 2015 euros

Reference

  • Luttjeboer J, et al. Threshold cost-effectiveness analysis for a therapeutic vaccine against HPV-16/18-positive cervical intraepithelial neoplasia in the Netherlands. Vaccine : 2 Nov 2016. Available from: URL: http://doi.org/10.1016/j.vaccine.2016.10.019

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

HPV vaccine cost saving for CIN and FIGO 1A in Netherlands. PharmacoEcon Outcomes News 766, 19 (2016). https://doi.org/10.1007/s40274-016-3540-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-016-3540-0

Search

Navigation